-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Tranexamic acid (TXA) can reduce surgical bleeding and reduce deaths caused by trauma and bleeding after delivery
.
However, it is effective for thrombotic events andEpilepsy affect seizures remains unclear
thrombusepilepsy
Recently, a research article was published in Critical Care, an authoritative journal in the field of critical care medicine.
Researchers conducted a systematic review and meta-analysis to evaluate the safety of TXA treatment in patients with bleeding
.
In this systematic review and meta-analysis, the researchers evaluated MEDLINE, EMBASE, and the Cochrane Registry of Randomized Controlled Trials.
The search time was from the establishment of the database to June 1, 2020
.
The researchers included randomized trials comparing the efficacy of intravenous tranexamic acid with placebo or no intervention in patients with bleeding
Stroke
A total of 234 studies and 102,681 patients were included in the meta-analysis
.
In bleeding patients, there is no evidence that TXA increases thrombotic events (RR=1.
Coronary Syndrome
Thus, tranexamic acid does not seem to increase the risk of thrombotic events in bleeding patients
.
However, because the risk of seizures may increase in a dose-dependent manner, very high doses of TXA should be avoided
Tranexamic acid does not seem to increase the risk of thrombotic events in bleeding patients
Original source:
Shuhei Murao.
Effect of tranexamic acid on thrombotic events and seizures in bleeding patients: a systematic review and meta-analysis in this message